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Respiratory syncytial virus group A strain variations of 28 isolates from The Netherlands collected during
three consecutive seasons were studied by analyzing G protein sequences. Several lineages circulated repeat-
edly and simultaneously during the respective seasons. No relationships were found between lineages on the
one hand and clinical severity or age on the other.
Respiratory syncytial virus (RSV) can be divided into two
groups, A and B, on the basis of the reaction with monoclonal
antibodies directed against the F and G proteins (1, 23) and
nucleotide sequence differences of several genes (5, 16, 30, 31).
These two groups circulate independently in the human pop-
ulation, with group A being the most prevalent (14, 23).
Also, within the two groups substantial strain differences
have been described, mainly associated with the divergence in
the gene encoding the G protein (17), which is the most vari-
able protein of the virus. Several lineages within groups A and
B also seem to cocirculate simultaneously in the population (3,
30). Studies on RSV strains show an accumulation of amino
acid changes over the years, suggesting antigenic drift-based,
immunity-mediated selection (4, 5, 8, 15, 27).
One of the most interesting features of RSV is its ability to
cause repeated infections throughout life (9, 11). This enables
RSV to remain present at high levels in the population, and it
has been estimated that at least 50% of children encounter
their first RSV infection during their first winter season. Strain
variation is thought to contribute to its ability to cause frequent
reinfections (4, 8, 32).
The clinical severity of RSV infection is associated with
epidemiological and host factors, which include socioeconomic
status (26), age (26), prematurity (25), and underlying heart
and/or lung disease (10, 19). Several studies have evaluated
differences in clinical severity between groups A and B. In
about half of these studies, no differences in clinical severity
were detected between the groups involved (14, 18, 21, 22, 28,
34, 37), and in the other studies, group A seemed to be asso-
ciated with more severe clinical disease (12, 13, 20, 23, 29, 33,
36). It has been suggested that virus variants within group A
are responsible for this discrepancy (7, 12, 36).
To further address this issue, we selected group A strains
from three consecutive winter seasons and subjected isolates of
these strains to sequence analyses of part of the G protein. The
strains were isolated from children for whom standardized
clinical data were available from a previous study concerning
RSV-A versus RSV-B and clinical severity (18).
RSV isolates (n 5 293) found in routine diagnostics during
three consecutive winter seasons were typed by performing
direct immune fluorescence on cells from nasopharyngeal
washings using specific monoclonal antibodies MAB 92-11C
for group A and MAB 109-10B for group B (Chemicon, Te-
mecula, Calif.) as previously described (2). Twenty-eight RSV
group A isolates were selected for sequence analysis.
All five group A strains available from the first season
(1992–1993) were included. Eleven from the second season
(1993–1994) and twelve from the third season (1994–1995)
were selected from children who had experienced either a mild
infection (not admitted) or a severe infection as determined by
clinical parameters upon admission (see below).
Demographic and clinical data on the children during the
acute phase and at the time of the control visit were collected
in a previous study (18). Briefly, the data included gender, age,
duration of pregnancy, underlying disease, feeding difficulties,
history of apnea, the presence of retractions, respiratory rate,
oxygen saturation (SaO2) in room air, partial CO2 pressure
(pCO2), pH, abnormalities on X rays, admission to an inten-
sive care unit, and the need for artificial ventilation. Severe
RSV infection was defined as meeting one or more of the
following criteria: pCO2 . 6.6 kPa, SaO2 , 90%, and/or the
need for artificial ventilation.
Viral RNA extraction and amplification of the viral RNA by
reverse transcriptase PCR were carried out as described pre-
viously (35). Briefly, RNA was extracted from 100 ml of culture
supernatant using a guanidinium isothiocyanate solution and
was collected by precipitation with isopropanol. The viral RNA
was then amplified by reverse transcriptase PCR using oligo-
nucleotide primers G(A)-173s (GGCAATGATAATCTCAAC
TTC) and G(A)-525as (TGAATATGCTGCAGGGTACT),
which resulted in an amplified fragment of 392 bp spanning the
first hypervariable region of the G protein (amino acids [aa]
100 to 132). The amplified products were subjected to nucle-
otide sequence analysis by cycle sequencing using an ABI dye
terminator sequencing system and analysis on an ABI Prism
377 DNA sequencer (PE Applied Biosystems, Nieuwerkerk
a/d IJssel, The Netherlands). Alignment of the nucleotide se-
quences of the G protein gene of the RSV isolates was carried
out using the GCG package (Madison, Wis.). Multiple se-
quence files were analyzed by DNAPARS in the PHYLIP
package (6). Subsequently, phenograms were generated using
the DRAWGRAM program.
Clinical data of patients from the respective seasons were
compared in a x2 test, Fisher’s exact test, or Mann-Whitney U
test when applicable.
During the three winter seasons, 232 children younger than
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12 months of age were diagnosed with a RSV infection by
direct immune fluorescence and/or virus isolation. In 1992–
1993 a predominance of group B viruses was found, season
1993–1994 showed a mixed epidemic, and in season 1994–1995
all children were infected with group A viruses (18). Figure 1
shows the numbers of RSV isolates in The Netherlands per
week during the three seasons. In the 1994–1995 season, a
short steep peak in the first weeks of December was observed.
During this third season, more children younger than 1 month
of age were admitted. Children in the third season had a higher
mean pCO2 and lower pH (Table 1) than children in the first
two seasons. No other differences in parameters known to
correlate with clinical severity could be objectively measured.
G protein amplicons of 28 RSV group A isolates divided
over the three seasons were studied by sequence analysis, and
a phenogram was generated (Fig. 2). Season of infection, age
upon diagnosis, and clinical parameters—severity score, artifi-
cial ventilation, and apnea—are indicated in the phenogram.
Several lineages of RSV were found to be present during the
three seasons studied, and several lineages could be identified
during all three seasons. Closely related strains were also
found to occur in subsequent seasons. The observed clustering
of the RSV isolates proved to be independent of season or
patient-related parameters (Fig. 2).
Thus, several lineages of RSV-A cocirculated during the
three seasons studied, and clinically severe as well as milder
cases were evenly distributed over the different lineages found.
RSV infections are usually found during several months in
the winter season. In the 1994–1995 season, a relatively high
incidence of RSV infections during a relatively short period
was found. In the 1994–1995 season, more children from the
very young age group were admitted. The only clinical param-
eters objectively found to be more severe in the 1994–1995
season were the pCO2 and the pH. These parameters may be
directly related to the younger age of the children involved,
since a significant relationship between pCO2 and age has been
previously described (24).
The RSV-G protein is the most variable of the RSV pro-
teins; therefore, we chose to sequence a variable part of the
RSV-G protein to study strain variation within subgroup A.
However, it is not known where in the RSV genome putative
virulence factors would be located. Since we sequenced only a
small part of the genome, it cannot be fully excluded that
mutations important for virulence elsewhere on the RSV ge-
nome were missed.
The isolates from the 1994–1995 season were all of group A.
We investigated whether this peak represented a single, pos-
sibly more virulent, strain of RSV-A. Despite the limited num-
ber of strains that were sequenced, it was clear that in the
1994–1995 season, as well as in the other two seasons, several
different strains cocirculated, and severe infections or younger
age proved not to be related to one particular strain. In addi-
tion, closely related strains were found during different sea-
sons, as has been described previously (3, 8, 30).
FIG. 1. Number of RSV isolates per week during the three seasons studied, as recorded by the combined Dutch Virology Laboratories. (Published with permission
of the Dutch Working Group on Clinical Virology.)






No. of children 130 102 NS
No. (%) ,37 mo gestation 37 (28.5) 21 (20.5) NS
No. (%) ,1 mo old 9 (6.9) 17 (16.7) 0.035
Mean (SD) respiratory rate 51.9 (13.4) 51.6 (20.3) NS
No. (%) with history of apnea 23 (17.7) 23 (22.5) NS
No. (%) wheezing 47 (36.1) 34 (33.2) NS
Mean (% SD) pCO2 6.1 (1.4) 6.93 (2.35) 0.027
Mean (SD) pH 7.36 (0.07) 7.33 (0.11) 0.040
Mean (SD) SaO2 90.7 (8.7) 89.9 (12.2) NS
No. (%) on artificial ventilation 13 (10.0) 15 (14.7) NS
No. (%) with severe RSVb 51 (39.2) 46 (45.1) NS
a Clinical data of patients were compared in a x2 test, Fisher’s exact test, or
Mann-Whitney U test when applicable. NS, no statistical difference.
b Severe RSV infection was defined as meeting one or more of the following
criteria: pCO2 . 6.6 kPa, SaO2 , 90%, and/or on artificial ventilation.
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Collectively, our data show that during a winter season when
relatively many children are admitted during a relatively short
period, several strains may cocirculate in the population. In
addition, it was shown that clinically more severe cases were
found spread over the branches of the phylogenetic tree.
Therefore, severity of infection could not be attributed to par-
ticular lineages of RSV.
We thank Conny Kruyssen for assistance in preparing the manuscript.
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